The short answer
Glazova and colleagues reported in Neuropeptides in 2021 that Semax attenuated behavioural and neurochemical alterations following early-life fluvoxamine exposure in rats. In that model a disturbance is induced first and the compound tested against it.
Key facts
- Study
- Glazova 2021 (PMID 33418449)
- Journal
- Neuropeptides, April 2021
- Species
- Rats
- Model
- Early-life fluvoxamine exposure
- Measured
- Behavioural and neurochemical outcomes
- Design type
- Induced disturbance, then intervention
What the model does
Fluvoxamine is a selective serotonin reuptake inhibitor, and exposure during early development perturbs serotonergic system maturation in ways that produce measurable behavioural and neurochemical differences later. The model creates a defined disturbance rather than observing a naturally occurring one.
Why an induced-disturbance design is stronger than it looks
Testing whether a compound changes behaviour in healthy animals asks a vague question, since there may be nothing to change. Inducing a specific, characterised alteration first gives a defined thing to act against and a defined direction of expected effect. It is a more demanding test than an open-ended behavioural screen.
Research material referenced
Semax 10mg, third-party HPLC tested
Why measuring neurochemistry alongside behaviour matters
Behaviour alone shows that something differs; neurochemistry indicates where. Reporting both allows a behavioural change to be connected to a biochemical one rather than left as an unexplained observation, and disagreement between the two levels is itself informative.
What attenuated means and does not mean
That the measured alterations were smaller in treated animals than in untreated ones. It does not mean they were abolished, nor that the underlying process was reversed. Attenuation is a quantitative statement about a difference between groups in one model.
The limits of the design
A developmental perturbation in rats is not a model of any human condition, and it was not built to be one. It is a tool for asking whether a compound can counteract a specific induced change. Extending that to a claim about people requires evidence of an entirely different kind, which does not exist here.
What is not claimed
Anything about behaviour, cognition or neurochemistry in any person. Semax holds no marketing authorisation from the MHRA, EMA or FDA, and material supplied here is for laboratory research only.
Frequently asked questions
What model did the 2021 study use?
Early-life fluvoxamine exposure in rats, which perturbs serotonergic development and produces measurable behavioural and neurochemical differences.
Why induce a disturbance first?
It gives a defined thing to act against and a defined expected direction, which is a more demanding test than an open-ended behavioural screen.
Does 'attenuated' mean reversed?
No. It means the measured alterations were smaller in treated animals than untreated ones, in that model.
Continue researching
Related guides and reference material.
Primary sources & clinical trials
Published papers, trial registrations, regulator pages and company announcements. Links open the original.
- PubMedGlazova NY et al., Semax, synthetic ACTH(4-10) analogue, attenuates behavioural and neurochemical alterations following early-life fluvoxamine exposure. Neuropeptides 2021 (PMID 33418449)pubmed.ncbi.nlm.nih.gov
- PubMedKolbaev SN et al. Bull Exp Biol Med 2025 (PMID 41171324)pubmed.ncbi.nlm.nih.gov
Written and published by UK Peptides, the trading name of AURYXRESEARCH LTD (company 17388727, registered in England and Wales).
Questions or a correction? Email hello@ukpeptides.org or call +44 7426 987848.
More Semax (ACTH Fragment Peptide) articles
- What a Fragment Keeps Decides What It DoesThree fragments of alpha-MSH pursue pigmentation, inflammation and cognition. The difference is not the parent - it is which residues each retained.
- What Is Semax? Origin, Sequence and Neurotrophin MechanismSemax is a synthetic heptapeptide derived from an ACTH fragment, developed in Russia. Structure, neurotrophin mechanism and regulatory status.
- Is Semax Really an ACTH(4-10) Analogue?Semax is universally called an ACTH(4-10) analogue, but shares only residues 4-7. Pro-Gly-Pro replaces Arg-Trp-Gly, and that substitution is the point.
- Semax Structure, Sequence and Physical PropertiesSemax is MEHFPGP, 7 residues, 813.9 Da, C37H51N9O10S. Sequence features, the two prolines, the single methionine, and what each means for handling.
- What Are Glyprolines? The Pro-Gly-Pro Motif ExplainedPro-Gly-Pro is a collagen-derived tripeptide used to stabilise designed peptides. Why proline resists peptidases, and what it contributes to Semax and Selank.